PER 6.76% 7.9¢ percheron therapeutics limited

Read the last paragraph of my previous post...Mark Diamond ticks...

  1. 13,150 Posts.
    lightbulb Created with Sketch. 1382
    Read the last paragraph of my previous post...Mark Diamond ticks all the boxes...

    Mark Diamond
    Managing Director

    Mark Diamond has over 20 years’ experience in the pharmaceutical and biotechnology industry. Before joining Antisense Therapeutics Limited as MD and CEO in 2001, Mr. Diamond was employed in the US as Director, Project Planning/Business Development at Faulding Pharmaceuticals. Prior to this he held the positions of Senior Manager, Business Development and In-licensing within Faulding’s European operation based in the UK and International Business Development Manager with Faulding in Australia.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.